This special report focuses on the explosive allegations of electoral fraud levelled by Congress leader Rahul Gandhi against the Election Commission of India (ECI) and the BJP. Aishwarya Pallival ...

The new Gemini 2.5 Computer Use model can click, scroll, and type in a browser window to access data that’s not available via an API. The new Gemini 2.5 Computer Use model can click, scroll, and type ...

This article is part of Kotaku Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Finding the right pair of noise-canceling headphones ...

This article is part of Kotaku Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Budget robot vacuum cleaners have three huge ...

ATHENS — Georgia football fans figure to have new travels ahead sooner than later with the SEC’s decision to move to a nine-game league schedule. The new scheduling model, announced by SEC ...

The recent Vertex Pharmaceuticals Incorporated stock drop after VX-993 trial results is overblown; the pain franchise remains robust with multiple promising avenues and ongoing trials. Vertex's CF ...

Vertex Pharmaceuticals (VRTX) plunged after Q2 earnings and is now down 21% over the past year. The company has historically had a strong R&D pipeline and has consistently been a winner, but the ...

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) reported better-than-expected earnings for the second quarter after the market close on Monday. The company's revenue came in at $2.97 billion versus estimates ...

After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit a snag on its path to expand the potential blockbuster’s reach into ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data from the Phase 1/2 portion of the Phase 1/2/3 ...